Analysis of standard vs dose-escalated stereotactic body radiation therapy in localized prostate cancer: a comparative evaluation of survival outcomes
Escalating the biologically effective dose above standard levels did not yield a significant improvement in tumor control or survival outcomes compared to conventional SBRT dosing for localized PCa. Further prospective studies are warranted to clarify the role of dose escalation in this setting.
Authors
- Huojun Zhang (ORCID: https://orcid.org/0009-0003-4327-3498)
- Tingting Wei (ORCID: https://orcid.org/0000-0002-0852-9035)
- Bichun Xu
- Liang Chen (ORCID: https://orcid.org/0000-0001-9986-5335)
- Weiwei Zhang (ORCID: https://orcid.org/0000-0003-2765-5376)
- Zuping Lian
- Yiyin Liang
Institutions
- Tongji University (CN)
- Soochow University (CN)
- Second Affiliated Hospital of Soochow University (CN)
- Ruikang Affiliated Hospital of Guangxi Medical University (CN)
- Tongji Hospital (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-08-13
- DOI
- https://doi.org/10.3389/fimmu.2025.1654174
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Changhai Hospital of Shanghai